BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Clinical trials for BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM trials appear
Sign up with your email to follow new studies for BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cord blood transplant method aims to beat high-risk blood cancers
Disease control Recruiting nowThis study tests a special cord blood transplant for people with high-risk blood cancers like leukemia and lymphoma. Participants get chemotherapy and radiation before the transplant to kill cancer cells and prepare the body. After the transplant, drugs are given to prevent the n…
Matched conditions: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 23:49 UTC
-
New combo therapy targets hard-to-treat blood cancers
Disease control Recruiting nowThis early-phase study tests a new drug, SL-401, combined with standard treatments (azacitidine and venetoclax) for people with certain blood cancers like acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and blastic plasmacytoid dendritic cell neoplasm (BPDCN). The g…
Matched conditions: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Promising combo targets rare blood cancer BPDCN in new trial
Disease control Recruiting nowThis study tests a combination of two targeted drugs (tagraxofusp and venetoclax) plus chemotherapy for people with a rare and aggressive blood cancer called BPDCN. The goal is to see if this approach can shrink or eliminate the cancer and improve how long patients live without t…
Matched conditions: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Could removing certain immune cells prevent a devastating transplant complication?
Disease control Recruiting nowThis study is for children and young adults with blood cancers who are getting a donor stem cell transplant. The goal is to see if removing a specific type of immune cell (naive T cells) from the donated cells can prevent chronic graft-versus-host disease, a serious condition whe…
Matched conditions: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New drug MGD024 targets tough blood cancers in early human trial
Disease control Recruiting nowThis early-phase study tests a new drug called MGD024 in about 130 adults with certain blood cancers (like leukemia or lymphoma) that have not improved with standard treatments or have returned. The main goal is to find the safest dose and understand side effects. Participants re…
Matched conditions: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC